{"id":"W4221107975","doi":"10.1002/pbc.29633","title":"Selumetinib for symptomatic, inoperable plexiform neurofibromas in children with neurofibromatosis type 1: A national real‐world case series","year":2022,"lang":"en","type":"article","venue":"Pediatric Blood & Cancer","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba; Centre hospitalier universitaire de Québec; Centre Hospitalier Universitaire Sainte-Justine; University of Toronto; SickKids Foundation; University of Alberta; Université Laval; Stollery Children's Hospital; Hospital for Sick Children","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Sick Kids Foundation","keywords":"Medicine; Selumetinib; Neurofibromatosis; Trametinib; Plexiform neurofibroma; Oncology; Dermatology; Population; MEK inhibitor; Internal medicine; MAPK/ERK pathway; Pediatrics; Surgery; Cancer; Neurofibroma; Radiology; Kinase","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002632238,0.0006720444,0.0004440613,0.000981615,0.001119696,0.0006870941,0.000488673,0.001207099,0.001654672],"category_scores_gemma":[0.001382452,0.0003445242,0.000483886,0.0008405449,0.001000744,0.0008756375,0.0006852337,0.0009359394,0.0003342461],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001102685,"about_ca_system_score_gemma":0.0009035919,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002357679,"about_ca_topic_score_gemma":0.007107531,"domain_scores_codex":[0.9995926,0.00004866897,0.0000581419,0.00008714011,0.0001179577,0.00009542809],"domain_scores_gemma":[0.9990571,0.000233103,0.0003101317,0.00005354813,0.00007496904,0.0002711547],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.00005368146,0.00007008042,0.09878246,0.00009814958,0.00004352579,0.890664,0.0004600817,0.0002852694,0.000991555,0.000304734,0.001173945,0.007072683],"study_design_scores_gemma":[0.000006763317,0.00004353588,0.01585734,0.00001902697,0.00001586161,0.9826199,0.00021304,0.00009862125,0.0002829128,0.00004642917,0.000790819,0.000005708057],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9888425,0.002930277,0.0009729117,0.0009494973,0.0000512964,0.0001033178,0.0002997303,0.00003666348,0.005813778],"genre_scores_gemma":[0.9969636,0.001314164,0.0008495101,0.0002272247,0.00006585467,0.00002157821,0.0001372532,0.00001303366,0.0004078021],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002357679,"threshold_uncertainty_score":0.008000612,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01989402577293096,"score_gpt":0.2728560403049798,"score_spread":0.2529620145320488,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}